IPM’s insider coverage of the AMP meeting

AMP 2024: Trends and Insights from Vancouver

Inside Precision Medicine’s VP and publisher Bill Levine joins North American Editor Jonathan D. Grinstein, PhD, for a recap of how the molecular pathology community—from clinical labs and health systems to the biopharma industry—is reacting to the FDA’s ruling on laboratory-developed tests (LDTs), integrating advancements in digital pathology and precision medicine into clinical care, and more. Produced by Bill Levine Hosted by Jonathan D. Grinstein Music provided by Oleksii Holubiev Audio mixed and mastered by Jason Mack ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.